Fjarde Ap Fonden 10x Genomics, Inc. Transaction History

Fjarde Ap Fonden

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$36.95 - $82.41 $522,916 - $1.17 Million	-14,152 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$55.7 - $145.79 $464,983 - $1.22 Million	-8,348 Reduced 37.1%	14,152 $1.08 Million
Q4 2021 Feb 15, 2022	SELL	$135.05 - $182.59 $135,050 - $182,590	-1,000 Reduced 4.26%	22,500 $3.35 Million
Q1 2021 May 17, 2021	SELL	$140.25 - $196.86 $154,275 - $216,546	-1,100 Reduced 4.47%	23,500 $4.25 Million
Q4 2020 Feb 12, 2021	BUY	$126.47 - $163.7 $3.11 Million - $4.03 Million	24,600 New	24,600 $3.48 Million

296

92.5M

162K

107K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.42B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

Stay updated on Fjarde Ap Fonden with notifications on news.